Koninklijke Philips (PHG) Cash from Discontinued Operations (2009 - 2025)
Koninklijke Philips' (PHG) quarterly Cash from Discontinued Operations came in at 11640435.15 in Q4 2025, up 16.21% year-on-year from 10017062.97 in Q4 2024, and little changed quarter-over-quarter from 11690550.91 in Q3 2025.
Koninklijke Philips (PHG) Cash from Discontinued Operations (2009 - 2025) Analysis & Trends
Koninklijke Philips' Cash from Discontinued Operations history runs 17 years deep, the most recent figure standing at 11640435.15 for Q4 2025.
- On a quarterly basis, Cash from Discontinued Operations rose 16.21% year-over-year to 11640435.15 in Q4 2025; TTM through Dec 2025 was 45169427.34, a 34.85% increase from a year earlier, with the FY2023 full-year figure at 132340608.8, up 580.42% from the prior year.
- Cash from Discontinued Operations steadied at 11640435.15 in Q4 2025 per PHG's latest filing, from 11690550.91 in the prior quarter.
- Across five years, Cash from Discontinued Operations topped out at 4552049064.24 in Q3 2021 and bottomed at 61889287.92 in Q2 2022.
- The 5-year median for Cash from Discontinued Operations is 10919220.64 (2025), against an average of 424390806.45.
- Across the five-year window, Cash from Discontinued Operations soared 2431.08% in 2021 and plunged 330.16% in 2024, its largest moves.
- Year by year, Cash from Discontinued Operations stood at 3892933146.71 in 2021, then plunged by 100.31% to 12242968.38 in 2022, then jumped by 275.76% to 21518798.18 in 2023, then tumbled by 164.56% to 13891740.2 in 2024, then increased by 16.21% to 11640435.15 in 2025.
- Per Business Quant, the three latest PHG Cash from Discontinued Operations figures stand at 11640435.15 (Q4 2025), 11690550.91 (Q3 2025), and 11319596.88 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -11.64 Mn |
| Dec 31, 2025 | -11.64 Mn |
| Sep 30, 2025 | -11.69 Mn |
| Sep 30, 2025 | -11.69 Mn |
| Jun 30, 2025 | -11.32 Mn |
| Jun 30, 2025 | -11.32 Mn |
| Mar 31, 2025 | -10.52 Mn |
| Mar 31, 2025 | -10.52 Mn |
| Dec 31, 2024 | -13.89 Mn |
| Dec 31, 2024 | -13.89 Mn |
| Sep 30, 2024 | -18.67 Mn |
| Sep 30, 2024 | -18.67 Mn |
| Jun 30, 2024 | -18.31 Mn |
| Jun 30, 2024 | -18.31 Mn |
| Mar 31, 2024 | -18.47 Mn |
| Mar 31, 2024 | -18.47 Mn |
| Dec 31, 2023 | 21.52 Mn |
| Dec 31, 2023 | 21.52 Mn |
| Sep 30, 2023 | 87.09 Mn |
| Sep 30, 2023 | 87.09 Mn |